TALEN

TALEN1-appa

ID

ZDB-TALEN-200930-3

Name

TALEN1-appa

Previous Names

None

Target

appa (1)

Target Sequence 1

5' - TCTTCATATTACTGATGG - 3'

Target Sequence 2

5' - TTTTCTTACCTCCACCGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
ua5005	appa
ua5006	appa
ua5007	appa
ua5008	appa

Expression

Gene expression in Wild Types + TALEN1-appa

No data available

Phenotype

Phenotype resulting from TALEN1-appa

No data available

Phenotype of all Fish created by or utilizing TALEN1-appa

Phenotype	Fish	Conditions	Figures
whole organism movement behavioral quality, abnormal	appa^{ua5005/ua5005} (AB)	chemical treatment by environment: 2-methyl-6-(phenylethynyl)pyridine hydrochloride, chemical treatment by environment: pentetrazol	Fig. 5 from Kanyo et al., 2020
whole organism movement behavioral quality, abnormal	appa^{ua5005/ua5005} (AB)	chemical treatment by environment: pentetrazol	Fig. 4, Fig. 5 from Kanyo et al., 2020
swimming behavior disrupted, exacerbated	appa^{ua5005/ua5005} (AB)	chemical treatment by environment: pentetrazol	Fig. 2 from Kanyo et al., 2020
whole organism decreased length, abnormal	appa^{ua5005/ua5005} (AB)	standard conditions	Fig. 1 from Kanyo et al., 2020
swimming behavior disrupted, abnormal	appa^{ua5005/ua5005} (AB)	chemical treatment by environment: pentetrazol	Fig. 4 from Kanyo et al., 2020
swimming behavior disrupted, abnormal	appa^{ua5005/ua5005} (AB)	chemical treatment by environment: pentetrazol	Fig. 4, Fig. 5 from Kanyo et al., 2020
whole organism movement behavioral quality, abnormal	appa^{ua5005/ua5005} (AB)	chemical treatment by environment: pentetrazol	Fig. 4 from Kanyo et al., 2020
swimming behavior disrupted, abnormal	appa^{ua5005/ua5005} (AB)	chemical treatment by environment: 2-methyl-6-(phenylethynyl)pyridine hydrochloride, chemical treatment by environment: pentetrazol	Fig. 5 from Kanyo et al., 2020
whole organism movement behavioral quality, exacerbated	appa^{ua5005/ua5005} (AB)	chemical treatment by environment: pentetrazol	Fig. 2 from Kanyo et al., 2020
swimming behavior disrupted, abnormal	appa^{ua5005/ua5005}; prnpb^{ua5003/ua5003} (AB)	chemical treatment by environment: pentetrazol	Fig. 4, Fig. S10 from Kanyo et al., 2020
whole organism decreased length, abnormal	appa^{ua5005/ua5005}; prnpb^{ua5003/ua5003} (AB)	standard conditions	Fig. S9 from Kanyo et al., 2020
whole organism movement behavioral quality, abnormal	appa^{ua5005/ua5005}; prnpb^{ua5003/ua5003} (AB)	chemical treatment by environment: pentetrazol	Fig. 4 from Kanyo et al., 2020
swimming behavior disrupted, exacerbated	appa^{ua5005/ua5005}; prnpb^{ua5003/ua5003} (AB)	chemical treatment by environment: pentetrazol	Fig. 4 from Kanyo et al., 2020
whole organism movement behavioral quality, exacerbated	appa^{ua5005/ua5005}; prnpb^{ua5003/ua5003} (AB)	chemical treatment by environment: pentetrazol	Fig. 4 from Kanyo et al., 2020
whole organism movement behavioral quality, ameliorated	appa^{ua5005/ua5005}; prnpb^{ua5003/ua5003} (AB)	chemical treatment by environment: 2-methyl-6-(phenylethynyl)pyridine hydrochloride, chemical treatment by environment: pentetrazol	Fig. 5 from Kanyo et al., 2020
whole organism movement behavioral quality, ameliorated	appa^{ua5005/ua5005}; prnpb^{ua5003/ua5003} (AB)	chemical treatment by environment: pentetrazol	Fig. 5, Fig. S10 from Kanyo et al., 2020

Citations